NCT02358629View on ClinicalTrials.gov

A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Chronic Total Occlusion

Interventions

DEVICE

NovaCross™ microcatheter

successful delivery, crossing, and retrieval of the investigational device as identified by confirmation of guidewire placement in the distal true lumen confirmed by angiography

Trial Locations (1)

Unknown

Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie, Krakow

All Listed Sponsors

lead

Nitiloop Ltd.

INDUSTRY

NCT02358629 - A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO). | Biotech Hunter | Biotech Hunter